A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene

Research Grant

Duke Scholars

Principal Investigator Richard Francis Riedel Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Arog Pharmaceuticals, Inc.

Start Date

January 16, 2017

End Date

November 30, 2020

Administered By

Duke Cancer Institute

Awarded By

Arog Pharmaceuticals, Inc.

Start Date

January 16, 2017

End Date

November 30, 2020